Med Spa Trends Statistics 2026

How widely are newer treatments offered?

23% of US med spas already offer peptide therapy (12,007 spas).

16% of US med spas already offer semaglutide (8,426 spas).

13% of US med spas already offer NAD+ IV therapy (7,056 spas).

11% of US med spas already offer Jeuveau (6,065 spas).

11% of US med spas already offer Morpheus8 (5,964 spas).

11% of US med spas already offer exosome therapy (5,956 spas).

11% of US med spas already offer tirzepatide (5,947 spas).

11% of US med spas already offer Daxxify (5,941 spas).

11% of US med spas already offer red light therapy (5,817 spas).

7.3% of US med spas already offer SkinVive (3,891 spas).

How fast are these trends moving?

This is our first snapshot (October 2026), so these are adoption levels today, not growth rates.

We will add year-over-year change once the next snapshot is published.

What published research says

These numbers come from outside sources, not our directory; each one links to its source below.

• ASPS 2025: the biggest percentage rises in cosmetic surgery were facial fat grafting (+39%), forehead/brow lift (+29%), upper body lift (+22%), arm lift and neck lift (+21% each) and thigh lift (+20%); declines were male breast reduction (-8%), rhinoplasty (-5%) and Brazilian butt lift (-5%). [1]
• ASPS 2025: adults 66 and older were the fastest-growing age group for cosmetic surgery (+24%), while ages 18-25 fell 9% and 26-35 fell 5%; ages 36-55 accounted for about 49% (738,000) of cosmetic procedures. [1]
• ASPS 2025: 82% of ASPS member surgeons reported consultation requests related to GLP-1 weight-loss medications. [1]
• ISAPS 2025 worldwide: the top surgeries were eyelid surgery (2,457,677, +16.2%), liposuction (1,849,828, -11.4%), breast augmentation (1,622,639), breast lift (1,143,862, +48.1%) and abdominoplasty (1,039,808); the top non-surgical procedures were botulinum toxin (7,333,647, -7.0%), hyaluronic acid (4,737,957, -25.2%), non-surgical skin tightening (1,528,552, +23.3%), hair removal (1,150,365) and chemical peel (659,942). [2]
• AbbVie's US Aesthetics net revenues were $2.990 billion in 2025 (down 8.5%), including US Botox Cosmetic $1.504 billion (down 10.5%) and US Juvederm $385 million (down 18.0%). [3]
• InMode (Morpheus8 and other RF devices) reported 2025 revenues of about $370.5 million, down 6% from $394.8 million in 2024; US revenue fell to about $198.7 million from $244.8 million. [4]

What these numbers can't tell you

• This is a single snapshot, so it shows where providers are today, not how fast the market is growing.
• A treatment counts when the spa's Google listing or website names it, so a spa with an outdated menu can be over- or under-counted.

Medical disclaimer. MedSpaStandard is for education only and is not medical advice. Talk to a licensed provider about your own health, and check any provider's license with your state board.